AI assistant
LUMIBIRD — Share Issue/Capital Change 2018
Dec 13, 2018
1490_iss_2018-12-13_279932e0-6db2-4f34-b4c4-33695178d7e8.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
- •
- •
- •
1 To date, the Company is not committed to any external growth projects that are underway.
Marc Le Flohic, Lumibird Group Chairman and CEO: "I would like to thank Lumibird's shareholders for having subscribed for this capital increase on a massive scale, highlighting their confidence in the Group's strategy and the outlook for its development. Thanks to this operation's success, we are further strengthening our financial resources and giving ourselves the means needed to take a further step forward with our development. This will involve integrating new technologies, through external growth or investment in new R&D projects".
The new shares' settlement-delivery and admission for trading on the regulated market Euronext Paris are scheduled for December 17, 2018. The new shares will be entitled to dividends from delivery and will be traded under the same listing as the existing shares (ISIN: $FROOOO38242$ ). They will be assimilated with and give the same rights as the existing shares from their issue.
LUMIBIRD is one of the world's leading specialists in lasers. With 50 years of experience and a mastering of solid state laser, laser diodes and fiber laser technologies, the Group designs, manufactures and markets high performance lasers for scientific (laboratories and universities), industrial (manufacturing, defense, Lidar sensors) and medical (ophthalmology) markets.
Born from the combination of Keopsys Group with Quantel in October 2017, LUMIBIRD has more than 400 employees and over €85 million of revenues (pro forma 2017) and is present in Europe, America and Asia.
LUMIBIRD shares are listed on the Euronext Paris C Compartment. FR0000038242 - LBIRD www.lumibird.com
Contacts
LUMIBIRD Marc Le Flohic Chairman and CEO Tel. +33(0) 1 69 29 17 00 [email protected]
LUMIBIRD Pierre Vallalta Chief Financial Officer Tel. +33(0) 1 69 29 17 00 [email protected]
Calvotus Mathieu Calleux Investor Relations Tel. +33(1) 53 65 37 91 [email protected] Midcap Partners Kevin Rolland Company advisor Tel. +33 (0)1 55 04 04 56 [email protected]